Gyre Therapeutics (GYRE) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free GYRE Stock Alerts $17.11 +0.78 (+4.78%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Gyre Therapeutics Stock Price Performance5 Day Performance+7.21%1 Month Performance-2.40%3 Month Performance+14.60%Year-To-Date Performance-33.40% Receive GYRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. GYRE Stock Chart for Saturday, April, 27, 2024 GYRE Chart by TradingView Gyre Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$16.33$17.11+4.78%$17.25$15.90190,123 shs$1.46 billion04/25/2024$16.05$16.33+1.74%$16.78$15.35137,161 shs$1.39 billion04/24/2024$15.94$16.05+0.69%$16.27$15.6331,808 shs$1.37 billion04/23/2024$15.96$15.94-0.13%$16.15$15.5339,480 shs$1.36 billion04/22/2024$15.51$15.96+2.90%$16.44$15.5266,005 shs$1.36 billion04/19/2024$15.41$15.51+0.65%$15.81$14.5958,832 shs$1.32 billion Get the Latest News and Ratings for GYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$15.84$15.41-2.71%$15.95$15.1038,055 shs$1.32 billion04/17/2024$16.00$15.84-1.00%$16.42$15.2642,070 shs$1.35 billion04/16/2024$16.48$16.00-2.91%$16.26$15.7955,505 shs$1.37 billion04/15/2024$16.81$16.48-1.96%$16.81$16.0048,999 shs$1.41 billion04/12/2024$16.45$16.81+2.19%$17.05$15.7862,603 shs$1.44 billion04/11/2024$13.88$16.45+18.52%$17.00$14.25120,471 shs$1.41 billion04/10/2024$17.00$13.88-18.35%$17.00$13.32221,494 shs$1.19 billion04/09/2024$16.86$17.00+0.83%$17.05$16.6151,769 shs$1.45 billion04/08/2024$16.95$16.86-0.53%$17.09$16.6862,248 shs$1.44 billion04/05/2024$16.98$16.95-0.18%$17.12$16.6559,958 shs$43.14 million04/04/2024$17.16$16.98-1.05%$17.33$16.2176,705 shs$43.13 million04/03/2024$16.99$17.16+1.00%$17.18$16.1360,581 shs$43.59 million04/02/2024$15.85$16.99+7.19%$17.00$15.5653,609 shs$43.16 million04/01/2024$17.48$15.85-9.32%$17.49$15.8070,470 shs$40.26 million03/29/2024$17.48$17.48$18.33$17.0772,408 shs$44.40 million03/28/2024$17.53$17.48-0.29%$18.33$17.0772,408 shs$44.40 million03/27/2024$16.79$17.53+4.41%$17.93$16.2171,488 shs$44.53 million03/26/2024$16.18$16.79+3.77%$17.77$16.4568,093 shs$42.65 million03/25/2024$17.59$16.18-8.02%$17.94$16.1539,744 shs$41.18 million03/22/2024$17.81$17.59-1.24%$18.18$17.1326,356 shs$44.50 million03/21/2024$17.86$17.81-0.28%$18.20$17.2937,031 shs$45.06 million03/20/2024$18.22$17.86-1.98%$18.55$17.4455,385 shs$45.24 million03/19/2024$18.15$18.22+0.39%$18.68$17.7074,429 shs$46.10 million03/18/2024$16.76$18.15+8.29%$18.38$16.7037,508 shs$45.92 million03/15/2024$18.82$16.76-10.95%$19.96$15.9177,063 shs$42.45 million03/14/2024$19.01$18.82-1.00%$19.85$18.2141,370 shs$47.62 million03/13/2024$17.65$19.01+7.71%$19.35$17.3542,173 shs$48.10 million03/12/2024$16.33$17.65+8.08%$17.96$16.2514,879 shs$44.65 million03/11/2024$17.24$16.33-5.28%$17.96$16.3230,482 shs$41.36 million03/08/2024$19.52$17.24-11.68%$20.09$16.5869,046 shs$43.62 million03/07/2024$20.68$19.52-5.61%$21.17$19.5141,815 shs$49.39 million03/06/2024$20.42$20.68+1.27%$20.98$19.8917,285 shs$52.38 million03/05/2024$21.55$20.42-5.24%$22.00$20.2033,703 shs$51.66 million03/04/2024$20.58$21.55+4.71%$21.83$19.6954,104 shs$54.52 millionMy top 100 stocks… (Ad)We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here.03/01/2024$18.14$20.58+13.45%$20.93$16.5071,954 shs$52.07 million02/29/2024$24.79$18.14-26.83%$22.90$18.14170,985 shs$45.89 million02/28/2024$22.72$24.79+9.11%$25.94$22.0196,303 shs$62.72 million02/27/2024$25.05$22.72-9.30%$26.37$22.3782,544 shs$57.48 million02/26/2024$22.03$25.05+13.71%$25.05$22.02131,688 shs$63.38 million02/23/2024$16.00$22.03+37.69%$24.07$15.75378,495 shs$55.74 million02/22/2024$14.13$16.00+13.23%$16.47$14.0763,118 shs$40.48 million02/21/2024$15.14$14.13-6.67%$15.30$13.5543,974 shs$35.79 million02/20/2024$15.38$15.14-1.56%$16.59$14.2978,381 shs$38.30 million02/19/2024$15.38$15.38$18.50$15.33120,600 shs$38.91 million02/16/2024$15.97$15.38-3.69%$18.50$15.33120,645 shs$38.96 million02/15/2024$14.77$15.97+8.12%$16.23$14.31129,986 shs$40.40 million02/14/2024$10.56$14.77+39.87%$15.65$10.90157,141 shs$37.37 million02/13/2024$11.41$10.56-7.45%$11.73$10.4797,121 shs$26.72 million02/12/2024$11.96$11.41-4.60%$12.78$11.3546,118 shs$28.87 million02/09/2024$12.31$11.96-2.84%$13.06$11.9073,212 shs$30.26 million02/08/2024$11.96$12.31+2.93%$13.00$11.6068,162 shs$31.14 million02/07/2024$11.38$11.96+5.10%$12.50$11.12124,173 shs$30.26 million02/06/2024$13.29$11.38-14.37%$14.25$10.81167,909 shs$28.83 million02/05/2024$11.50$13.29+15.57%$13.29$11.5061,395 shs$33.62 million02/02/2024$12.19$11.50-5.66%$12.85$10.9379,777 shs$29.10 million02/01/2024$12.37$12.19-1.46%$13.50$12.0785,931 shs$30.84 million01/31/2024$14.28$12.37-13.38%$14.77$12.2192,392 shs$31.30 million01/30/2024$15.41$14.28-7.33%$15.75$14.1743,100 shs$36.13 million01/29/2024$14.93$15.41+3.22%$15.60$14.4283,888 shs$38.99 million01/26/2024$15.31$14.93-2.48%$16.05$14.9187,120 shs$37.77 million Related Companies: Arcus Biosciences Stock Chart Zai Lab Stock Chart Kura Oncology Stock Chart ANI Pharmaceuticals Stock Chart Verona Pharma Stock Chart Gemini Therapeutics Stock Chart Morphic Stock Chart Ligand Pharmaceuticals Stock Chart Day One Biopharmaceuticals Stock Chart Pacira BioSciences Stock Chart Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GYRE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.